| Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes ZM Younossi, AB Koenig, D Abdelatif, Y Fazel, L Henry, M Wymer Hepatology 64 (1), 73-84, 2016 | 11540 | 2016 |
| The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 7279 | 2018 |
| Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Z Younossi, QM Anstee, M Marietti, T Hardy, L Henry, M Eslam, J George, ... Nature reviews Gastroenterology & hepatology 15 (1), 11-20, 2018 | 5325 | 2018 |
| The diagnosis and management of non‐alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Hepatology 55 (6), 2005-2023, 2012 | 5209 | 2012 |
| Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity CA Matteoni, ZM Younossi, T Gramlich, N Boparai, YC Liu, ... Gastroenterology 116 (6), 1413-1419, 1999 | 4524 | 1999 |
| Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults G Vernon, A Baranova, ZM Younossi Alimentary pharmacology & therapeutics 34 (3), 274-285, 2011 | 4233 | 2011 |
| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 3150 | 2023 |
| MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 3082 | 2020 |
| The utility of radiological imaging in nonalcoholic fatty liver disease S Saadeh, ZM Younossi, EM Remer, T Gramlich, JP Ong, M Hurley, ... Gastroenterology 123 (3), 745-750, 2002 | 2583 | 2002 |
| Sofosbuvir for previously untreated chronic hepatitis C infection E Lawitz, A Mangia, D Wyles, M Rodriguez-Torres, T Hassanein, ... New England Journal of Medicine 368 (20), 1878-1887, 2013 | 2449 | 2013 |
| Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease C Estes, H Razavi, R Loomba, Z Younossi, AJ Sanyal Hepatology 67 (1), 123-133, 2018 | 2418 | 2018 |
| The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of … N Chalasani, Z Younossi, JE Lavine, AM Diehl, EM Brunt, K Cusi, ... Gastroenterology 142 (7), 1592-1609, 2012 | 2225 | 2012 |
| Non-alcoholic fatty liver disease–a global public health perspective ZM Younossi Journal of hepatology 70 (3), 531-544, 2019 | 2173 | 2019 |
| Telaprevir for retreatment of HCV infection S Zeuzem, P Andreone, S Pol, E Lawitz, M Diago, S Roberts, R Focaccia, ... New England Journal of Medicine 364 (25), 2417-2428, 2011 | 2141 | 2011 |
| Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States RJ Wong, M Aguilar, R Cheung, RB Perumpail, SA Harrison, ... Gastroenterology 148 (3), 547-555, 2015 | 2122 | 2015 |
| The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis ZM Younossi, P Golabi, L de Avila, JM Paik, M Srishord, N Fukui, Y Qiu, ... Journal of hepatology 71 (4), 793-801, 2019 | 2079 | 2019 |
| Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ... Hepatology 65 (5), 1557-1565, 2017 | 1897 | 2017 |
| Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ... Hepatology 69 (6), 2672-2682, 2019 | 1876 | 2019 |
| Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008 ZM Younossi, M Stepanova, M Afendy, Y Fang, Y Younossi, H Mir, ... Clinical gastroenterology and hepatology 9 (6), 524-530. e1, 2011 | 1483 | 2011 |
| The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review ZM Younossi, P Golabi, JM Paik, A Henry, C Van Dongen, L Henry Hepatology 77 (4), 1335-1347, 2023 | 1465 | 2023 |
Jeffrey V LazarusCUNY Graduate School of Public Health and Health Policy (CUNY SPH)ایمیل تأیید شده در isglobal.org